Cargando…

Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma

Irradiation and temozolomide (TMZ) chemotherapy are the current standard treatments for glioblastoma multiforme (GBM), but they are associated with toxicity and limited efficacy. Recently, these standard therapies have been used to enhance immunotherapy against GBM. Immunotherapy using the anti-CD47...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gholamin, Sharareh, Youssef, Osama A, Rafat, Marjan, Esparza, Rogelio, Kahn, Suzana, Shahin, Maryam, Giaccia, Amato J, Graves, Edward E, Weissman, Irving, Mitra, Siddhartha, Cheshier, Samuel H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016411/ https://www.ncbi.nlm.nih.gov/pubmed/31547758 http://dx.doi.org/10.1177/1753425919876690

Ejemplares similares

Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo
por: Zhang, Michael, et al.
Publicado: (2016)

Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma
por: Hutter, Gregor, et al.
Publicado: (2019)

MBRS-31. COMBINING IRRADIATION AND ANTI-CD47 TO ENHANCE THE TREATMENT OF GROUP 3 MEDULLOBLASTOMA
por: Youssef, Osama, et al.
Publicado: (2020)

Casein Kinase 2α Regulates Glioblastoma Brain Tumor Initiating Cell Growth through the β-Catenin Pathway
por: Nitta, Ryan T., et al.
Publicado: (2014)

Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma
por: Kahn, Suzana A., et al.
Publicado: (2018)

Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma
por: Kahn, Suzana A., et al.
Publicado: (2018)

Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy
por: Zhu, Huaiyang, et al.
Publicado: (2017)

Tumor immunologic heterogeneity influences response to radiation and combination immunotherapy
por: Aguilera, Todd, et al.
Publicado: (2015)

The anti‐hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ‐dependent inhibition of the AKT pathway
por: Assad Kahn, Suzana, et al.
Publicado: (2016)

Telomerase Activation and Rejuvenation of Telomere Length in Stimulated T Cells Derived from Serially Transplanted Hematopoietic Stem Cells
por: Allsopp, Richard C., et al.
Publicado: (2002)

Telomere Shortening Accompanies Increased Cell Cycle Activity during Serial Transplantation of Hematopoietic Stem Cells
por: Allsopp, Richard C., et al.
Publicado: (2001)

The Role of Apoptosis in the Regulation of Hematopoietic Stem Cells: Overexpression of BCL-2 Increases Both Their Number and Repopulation Potential
por: Domen, Jos, et al.
Publicado: (2000)

Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma
por: Mohanty, Suchismita, et al.
Publicado: (2019)

γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth
por: Bui, Timothy T, et al.
Publicado: (2015)

CD47-blocking therapies stimulate macrophage cytokine secretion and are effective in a model of peritoneal carcinomatosis
por: Weiskopf, Kipp, et al.
Publicado: (2015)

Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect
por: Nishiga, Yoko, et al.
Publicado: (2022)

Temozolomide is additive with cytotoxic effect of irradiation in canine glioma cell lines
por: Tresch, Nina Simona, et al.
Publicado: (2021)

In Vitro Macrophage-Mediated Phagocytosis Assay of Brain Tumors
por: Gardner, Madison, et al.
Publicado: (2020)

(47)Sc production development by cyclotron irradiation of (48)Ca
por: Misiak, R., et al.
Publicado: (2017)

Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
por: Chao, Mark P., et al.
Publicado: (2020)

HIF‐2: The Missing Link Between Obesity and Cardiomyopathy
por: Giaccia, Amato J.
Publicado: (2013)

The tumour microenvironment links complement system dysregulation and hypoxic signalling
por: Olcina, Monica M, et al.
Publicado: (2019)

Cerebral Coagulation Complications Following COVID-19 Adenoviral Vector Vaccines: A Systematic Review
por: Aghabaklou, Sara, et al.
Publicado: (2021)

Triple combination of lomustine, temozolomide and irradiation reduces canine glioma cell survival in vitro
por: Fuchs, Daniel, et al.
Publicado: (2023)

Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines
por: Schatz, Julia, et al.
Publicado: (2022)

A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
por: Betancur, Paola A., et al.
Publicado: (2017)

CD47–SIRPα-targeted therapeutics: status and prospects
por: Maute, R., et al.
Publicado: (2022)

Clinical Decision Support Systems: Effective Solution for Diagnosis, Treatment, and Management of Patients Affected by Poisoning
por: MAHMOUDVAND, Zahra, et al.
Publicado: (2019)

Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice
por: Han, May H., et al.
Publicado: (2012)

Reprogramming the immunological microenvironment through radiation and targeting Axl
por: Aguilera, Todd A., et al.
Publicado: (2016)

Roles of PINK1, mTORC2, and mitochondria in preserving brain tumor-forming stem cells in a noncanonical Notch signaling pathway
por: Lee, Kyu-Sun, et al.
Publicado: (2013)

$\beta$ decay of $^{47}$Ar
por: Weissman, L, et al.
Publicado: (2004)

Blockade of CD47 increases survival of mice exposed to lethal total body irradiation
por: Soto-Pantoja, David R., et al.
Publicado: (2013)

The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment
por: Patties, Ina, et al.
Publicado: (2019)

Obstacles to Glioblastoma Treatment Two Decades after Temozolomide
por: Cruz, João Victor Roza, et al.
Publicado: (2022)

Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
por: Liu, Jie, et al.
Publicado: (2015)

Radiobiology for the Radiologist
por: Hall, Eric J, et al.
Publicado: (2011)

Radiobiology for the Radiologist
por: Hall, Eric J, et al.
Publicado: (2006)

The Receptor Tyrosine Kinase AXL in Cancer Progression
por: Rankin, Erinn B., et al.
Publicado: (2016)

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy
por: Wang, Hongfei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_roqnut4np5iq4kd6pbcg2l90jc